+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe DNA Vaccines Market 2019-2027

  • ID: 4827825
  • Report
  • Region: Europe
  • 83 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 3

FEATURED COMPANIES

  • Astellas Pharma, Inc.
  • Eli Lilly And Company
  • Eurogentec S.A.
  • Glaxosmithkline, Inc.
  • Merck & Co.
  • Novartis AG
  • MORE
Market Outlook

The author’s research on the Europe DNA vaccines market depicts that the market will grow at a stable pace with a CAGR of 41.47% in terms of revenue during the forecast period 2019-2027. The UK, France, Germany, Spain, Italy, Russia and countries in rest of Europe together form the market for DNA vaccines in the European region. The Germany DNA vaccine market is mainly driven by government initiatives and the supporting norms & policies of the government. The German government launched a program, which states that it is compulsory for all the kindergartens operating in the country to give a notice to the government if the parents of the students have not submitted precise proof of vaccination counseling for their respective children. Another program launched for curbing measles by the government has made a solid mark in the policy framework of the governmental system; it came into action in 2016, due to the rising cases of measles in the country. Measles is a severe challenge for the country, as it can lead to the emergence of complications concerning pneumonia and encephalitis. Various types of vaccines have tested and verified, but very few of them have made any influential impact. Thus the demand for DNA vaccines to treat chronic diseases is increasing at a steady pace in Germany.

Competitive Outlook
The biggest brands in the market are Merck & Co., Merial Limited (acquired by Boehringer Ingelheim), Novartis AG, Sanofi, VGXI, Vical, Incorporated, Xenetic Biosciences, Inc. and Zoetis, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Astellas Pharma, Inc.
  • Eli Lilly And Company
  • Eurogentec S.A.
  • Glaxosmithkline, Inc.
  • Merck & Co.
  • Novartis AG
  • MORE
1. Europe DNA Vaccines Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Outlook
2.2.1. Threat of New Entrants
2.2.2. Threats of Substitute Product
2.2.3. Bargaining Power of Buyer
2.2.4. Bargaining Power of Supplier
2.2.5. Intensity of Competitive Rivalry
2.3. Vendor Scorecard
2.4. Value Chain Outlook
2.5. Key Insights
2.6. Regulatory Framework
2.7. Key Buying Outlook
2.8. Market Drivers
2.8.1. Surge in New Vaccine Development
2.8.2. Rise in the Usage of DNA Vaccines for Animal Healthcare
2.8.3. Rising Prevalence of Chronic and Infectious Diseases
2.9. Market Restraints
2.9.1. Lack of Legal and Ethical Framework
2.9.2. Stringent Government Regulations
2.10. Market Opportunities
2.10.1. Growing Demand for Gene Therapy
2.10.2. Steady Vaccines Are Easy to Store and Transport
2.10.3. Increasing Number of Clinical Trials on Humans
2.11. Market Challenges
2.11.1. Variation in the Regulatory Pathway and the Points of Consideration Regarding Environmental Valuation

3. DNA Vaccines Market Outlook - by Type
3.1. Animal DNA Vaccine
3.2. Human DNA Vaccine

4. DNA Vaccines Market Outlook - by Application
4.1. Human Disease
4.2. Veterinary Disease

5. DNA Vaccines Market Outlook - by Technology
5.1. Plasmid DNA Vaccines
5.2. Plasmid DNA Delivery

6. DNA Vaccines Market Outlook - by Region
6.1. Europe
6.1.1. The United Kingdom
6.1.2. France
6.1.3. Germany
6.1.4. Spain
6.1.5. Italy
6.1.6. Russia
6.1.7. Rest of Europe

7. Competitive Landscape
7.1. Astellas Pharma, Inc.
7.2. Dendreon Corporation (Acquired by Sanpower Group)
7.3. Eli Lilly and Company
7.4. Eurogentec S.A.
7.5. Glaxosmithkline, Inc.
7.6. Inovio Pharmaceuticals, Inc.
7.7. Madison Vaccines, Incorporated (Mvi)
7.8. Merck & Co.
7.9. Merial Limited (Acquired by Boehringer Ingelheim)
7.10. Novartis AG
7.11. Sanofi
7.12. Vgxi
7.13. Vical, Incorporated
7.14. Xenetic Biosciences, Inc.
7.15. Zoetis, Inc.

8. Methodology & Scope
8.1. Research Scope
8.2. Sources of Data
8.3. Research Methodology

List of Tables
Table 1 Europe DNA Vaccines Market 2019-2027 ($ Million)
Table 2 Intervention and Phase of Some Diseases/Conditions
Table 3 Regulations to Follow Before Commercialization
Table 4 Temperature Requirement in Preservation for Various Vaccines
Table 5 Approaches Being Tested to Enhance the Low Immunogenicity
Table 6 Clinical Trials on Humans Involving DNA Vaccines
Table 7 Europe DNA Vaccines Market by Type 2019-2027 ($ Million)
Table 8 Europe DNA Vaccines Market by Application 2019-2027 ($ Million)
Table 9 Europe DNA Vaccines Market by Technology 2019-2027 ($ Million)
Table 10 Europe DNA Vaccines Market by Country 2019-2027 ($ Million)

List of Figures
Figure 1 Europe DNA Vaccines Market 2019-2027 ($ Million)
Figure 2 Value Chain Analysis for DNA Vaccine Industry
Figure 3 Europe DNA Vaccines Market in Veterinary Diseases 2019-2027 ($ Million)
Figure 4 Clinical Trials of Gene Therapy
Figure 5 Europe DNA Vaccines Market in Animal DNA Vaccines 2019-2027 ($ Million)
Figure 6 Europe DNA Vaccines Market in Human DNA Vaccines 2019-2027 ($ Million)
Figure 7 Europe DNA Vaccines Market Share by Application 2017 & 2026 (%)
Figure 8 Europe DNA Vaccines Market in Human Diseases 2019-2027 ($ Million)
Figure 9 Europe DNA Vaccines Market in Veterinary Diseases 2019-2027 ($ Million)
Figure 10 Europe DNA Vaccines Market in Plasmid DNA Vaccines Technology 2019-2027 ($ Million)
Figure 11 Europe DNA Vaccines Market in Plasmid DNA Delivery Technology 2019-2027 ($ Million)
Figure 12 The United Kingdom DNA Vaccines Market 2019-2027 ($ Million)
Figure 13 France DNA Vaccines Market 2019-2027 ($ Million)
Figure 14 Germany DNA Vaccines Market 2019-2027 ($ Million)
Figure 15 Spain DNA Vaccines Market 2019-2027 ($ Million)
Figure 16 Italy DNA Vaccines Market 2019-2027 ($ Million)
Figure 17 Russia DNA Vaccines Market 2019-2027 ($ Million)
Figure 18 Rest of Europe DNA Vaccines Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Astellas Pharma, Inc.
  • Dendreon Corporation (Acquired By Sanpower Group)
  • Eli Lilly And Company
  • Eurogentec S.A.
  • Glaxosmithkline, Inc.
  • Inovio Pharmaceuticals, Inc.
  • Madison Vaccines, Incorporated (Mvi)
  • Merck & Co.
  • Merial Limited (Acquired By Boehringer Ingelheim)
  • Novartis AG
  • Sanofi
  • Vgxi
  • Vical, Incorporated
  • Xenetic Biosciences, Inc.
  • Zoetis, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll